-
Mashup Score: 2Coordinating Complex Care in High-Volume mHSPC Through Multidisciplinary Communication - Jonathan Henderson & Sunil Kakadia - 1 day(s) ago
Alicia Morgans convenes a discussion on managing high-volume metastatic hormone-sensitive prostate cancer, bridging the practices of urology and medical oncology with Jonathan Henderson and Sunil Kakadia, a medical oncologist from Genesis Oncology. They emphasize the importance of collaborative care in treating complex cases, like a patient presenting with high PSA levels, highlighting the…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 8Addressing the Intersection of Climate Change and Cancer: A Roadmap to Action for Urological Care Providers - Alexander Cole - 2 day(s) ago
Zach Klaassen and Alexander Cole discuss the impact of climate change on cancer screening, highlighting a study that explores public awareness of climate change’s health impacts and its association with cancer risk attitudes. Utilizing the HINTS database, they found a correlation between concern for climate change and interest in cancer screening, suggesting that awareness of environmental…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Addressing the intersection of #ClimateChange and #cancer: A roadmap to action for urological care providers. @Putnam_Cole @BWHUrology and @zklaassen_md @GACancerCenter discuss a study that explores public awareness of climate change's health impacts > https://t.co/HmVOCCTsHF https://t.co/BvRUtZEsqQ
-
-
Mashup Score: 0COBRA Trial Shows Promise for 64Cu-SAR-bisPSMA PET in Biochemical Recurrence - Neal Shore - 2 day(s) ago
Phillip Koo and Neal Shore discuss the COBRA trial, which investigates the use of 64Cu-SAR-bisPSMA PET imaging in prostate cancer patients with biochemical recurrence (BCR). Dr. Shore, the lead principal investigator, introduces Clarity, an Australian company developing Copper-64-based radiopharmaceuticals. He explains the advantages of Copper-64, such as its long half-life and bivalent…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 16Exploring the Complexities of Bladder Cancer Surveillance: Cytology, UroVysion, and Beyond - Komal Pohar & Kelly Bree - 2 day(s) ago
Ashish Kamat engages with Kamal Pohar and Kelly Bree on bladder cancer surveillance. They discuss the ongoing debate about the utility of various urinary markers in monitoring bladder cancer. Dr. Pohar mentions his reliance on cytology, while Dr. Bree adds that she uses cytology and occasionally UroVysion FISH for atypical cases, and also blue light cystoscopy despite its challenges. They both…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 6Revolutionizing Pelvic Organ Prolapse Treatment: Innovative 3D-Printed Pessaries - Bilal Iftikhar Chughtai - 2 day(s) ago
Diane Newman interviews Bilal Chughtai about an innovative patient-centered pelvic floor prolapse device developed by Cosm. Dr. Chughtai explains that the traditional method of pessary fitting is trial-and-error, which can be frustrating for patients. Cosm’s new technology uses 3D printing to create custom-fitted pessaries based on precise measurements of the prolapse, offering a more tailored…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 8Bone Health in Advanced Prostate Cancer: Findings from the STAMPEDE Trial and Hospital Episode Statistics - Noel Clarke - 2 day(s) ago
Alicia Morgans engages with Noel Clarke on the critical issue of bone health in prostate cancer patients, particularly those undergoing androgen deprivation therapy (ADT). Professor Clarke shares findings from the STAMPEDE trial and other studies that highlight the high fracture rates in these patients. He criticizes the reliability of the FRAX scoring system, which was originally developed for…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 7Navigating the Expanding Landscape of BCG-Unresponsive NMIBC Treatment Options - Mark Tyson - 2 day(s) ago
Zachary Klaassen discusses the future of bladder cancer treatment with Mark Tyson. They explore the challenges of sequencing treatments for non-muscle invasive bladder cancer, particularly in BCG-naive and unresponsive patients. Dr. Tyson emphasizes the evolving landscape with multiple emerging drugs like Adstiladrin and N-803, which recently received FDA approval. They examine the difficulty in…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 8COBRA Trial Shows Promise for 64Cu-SAR-bisPSMA PET in Biochemical Recurrence - Neal Shore - 2 day(s) ago
Phillip Koo and Neal Shore discuss the COBRA trial, which investigates the use of 64Cu-SAR-bisPSMA PET imaging in prostate cancer patients with biochemical recurrence (BCR). Dr. Shore, the lead principal investigator, introduces Clarity, an Australian company developing Copper-64-based radiopharmaceuticals. He explains the advantages of Copper-64, such as its long half-life and bivalent…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 58
advances in the metastatic castrate-resistant prostate cancer (mCRPC), management of mCRPC patients, PSMAfore study, mCRPC patients in North America, poly ADP ribose polymerase (PARP) inhibitors and LuPSMA.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 5Sign up - 2 day(s) ago
UroToday – GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
#ASCO24 is quickly approaching! If you haven't already, don't forget to sign up for email coverage delivered straight to your inbox! #FollowUs on #SoMe to stay up to date for upcoming events and live coverage throughout the conference > https://t.co/ns2VmWFjg6 @ASCO #ASCO2024 https://t.co/x2sGIXCyji
-
Coordinating complex care in high-volume #mHSPC through multidisciplinary communication. Jonathan Henderson, MD @ArUrology & Sunil Kakadia, MD, MPH, FACP join @CaPsurvivorship @DanaFarber in this discussion on managing high-volume mHSPC > https://t.co/wB74NwGIJy https://t.co/eirLyGGyql